Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Baxter International
NYSE:BAX Community
1
Narratives
written by author
0
Comments
on narratives written by author
17
Fair Values set
on narratives written by author
Create a narrative
Baxter International
Popular
Undervalued
Overvalued
Baxter International
WA
Analyst Price Target
Consensus Narrative from 16 Analysts
Strong Demand In Advanced Surgery And Specialty Injectables Will Boost Future Performance
Key Takeaways A new verticalized operating model and strategic divestitures will enhance focus, boosting margins and driving profitable growth. Investments in innovation and new product launches are set to increase sales volumes and improve revenue growth.
View narrative
US$40.04
FV
13.0% undervalued
intrinsic discount
4.52%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
8 days ago
author updated this narrative
Your Valuation for
BAX
Baxter International
Your Fair Value
US$
Current Price
US$34.85
49.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-3b
13b
2015
2018
2021
2024
2025
2027
2030
Revenue US$13.2b
Earnings US$2.0b
Advanced
Set as Fair Value